Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • BrainChild Bio masterminds $116M series A for CAR-T’s pivotal push in pediatric brain cancer

BrainChild Bio masterminds $116M series A for CAR-T’s pivotal push in pediatric brain cancer

September 7, 2026Posted inBiotechnology

A startup spawned from Seattle Children’s Hospital has raised a $116 million series A to advance cell therapies for devastating childhood brain tumors.

Post navigation

Previous Post
youtube-comment-analysis-reveals-ideological-polarization-in-black-lives-matter-videos YouTube comment analysis reveals ideological polarization in Black Lives Matter videos
Next Post
Noble metal-modified dual MOFs boost photodegradation of carbamazepine noble-metal-modified-dual-mofs-boost-photodegradation-of-carbamazepine

Recent Posts

  • H5N1 Spreads Among Australian Wildlife as Flu Season Ramps Up
  • Precure Selects Helix as Multiomics Lab and AI Tools Provider
  • Andelyn Curator Biomanufacturing Platform Supports Fayuvi Gene Therapy Approval
  • China targets 25% share of global first-in-class drugs in new 5-year plan
  • Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top